1-8 of 8
sclerodermoid chronic graft-versus-host disease
Close
Save search
Sort by
Journal Articles

A Novel Targeted Approach to Achieve Immune System Reset: CD45-Targeted Antibody Drug Conjugates Enable Autologous HSCT, Ameliorate Disease in Autoimmune Models, Potently Kill Human Immune Cells from Normal Donors and MS Patients, and Achieve Immune Depletion in Non-Human Primates (NHP)

Free
Geoff O Gillard, Jennifer L Proctor, BS, Melissa L. Brooks, BS, Tahirih L Lamothe, BS, Sharon L. Hyzy, MS, Oliver Mikse, Sean McDonough, Rahul Palchaudhuri, PhD, Anjali Bhat, MS, Ganapathy N. Sarma, PhD, Prashant Bhattarai, Pranoti Sawant, MS, Bradley R Pearse, PhD, Charlotte F. Mcdonough, PhD, Anthony E. Boitano, PhD, Michael P. Cooke, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3208.
https://doi.org/10.1182/blood-2019-130752
Published: 2019
Journal Articles

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

Free
Ridhi Gupta, MD, Abdulwahab Albabtain, MD, Sally Arai, MD, Bernice Kwong, MD, Wen-Kai Weng, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3409.
https://doi.org/10.1182/blood-2018-99-113915
Published: 2018
Journal Articles

Ruxolinitib As Salvage Therapy for Chronic Graft-Versus-Host Disease

Free
Badri Modi, MD, Michael Hernandez-Henderson, B.A., Erin Kopp, Dongyun Yang, PhD, Karen Huelsman, R.N., Pietro Sollena, MD, Jasmine M. Zain, MD, Haris Ali, MD, Monzr M. Al Malki, MD, Ricardo Spielberger, MD, Sanjeet Dadwal, MD, Amandeep Salhotra, MD, Stephen J. Forman, MD FACP, Pablo Parker, MD, Ryotaro Nakamura, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1976.
https://doi.org/10.1182/blood.V130.Suppl_1.1976.1976
Published: 2017
Journal Articles

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Free
Yoshihiro Inamoto, MD, Barry Storer, PhD, Effie W. Petersdorf, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Lee Nelson, MD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 322.
https://doi.org/10.1182/blood.V118.21.322.322
Published: 2011
Journal Articles

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

Free
Clinical Trials & Observations
Kathryn J. Martires, Kristin Baird, Seth M. Steinberg, Lana Grkovic, Galen O. Joe, Kirsten M. Williams, Sandra A. Mitchell, Manuel Datiles, Fran T. Hakim, Steven Z. Pavletic, Edward W. Cowen
Journal: Blood
Blood (2011) 118 (15): 4250–4257.
https://doi.org/10.1182/blood-2011-04-350249
Published: 2011
Includes: Supplemental data
Journal Articles

Cracking the cement overcoat

Free
Georgia B. Vogelsang
Journal: Blood
Blood (2011) 118 (15): 4010–4012.
https://doi.org/10.1182/blood-2011-08-372300
Published: 2011
Journal Articles

Nilotinib as Salvage Therapy In Patients with Chronic Graft Versus Host Disease

Free
Louis Terriou, Leonardo Magro, Eva De Berranger, Jean-Pierre Jouet, MD, Ibrahim Yakoub-Agha, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2329.
https://doi.org/10.1182/blood.V116.21.2329.2329
Published: 2010
Journal Articles

Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease

Free
Brief Report
Leonardo Magro, Mohamad Mohty, Benoit Catteau, Valérie Coiteux, Patrice Chevallier, Louis Terriou, Jean-Pierre Jouet, Ibrahim Yakoub-Agha
Journal: Blood
Blood (2009) 114 (3): 719–722.
https://doi.org/10.1182/blood-2009-02-204750
Published: 2009